Additional PET/CT in week 5–6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?-Reference-Cited by-同舟云学术

Additional PET/CT in week 5–6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?

Published:2008-09 Issue:3 Volume:88 Page:335-341
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Gillham Charles,Zips Daniel,Pönisch Falk,Evers Carsten,Enghardt Wolfgang,Abolmaali Nasreddin,Zöphel Klaus,Appold Steffen,Hölscher Tobias,Steinbach Jörg,Kotzerke Jörg,Herrmann Thomas,Baumann Michael

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference49 articles.

1. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee;Saunders;Radiother Oncol,1999

2. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ 1995;311:899–909.

3. Dose and fractionation concepts in the primary radiotherapy of non-small cell lung cancer;Baumann;Lung Cancer,2001

4. Molecular targeting in radiotherapy of lung cancer;Baumann;Lung Cancer,2004

5. Improved local control with higher doses of radiation in large-volume stage III non-small cell lung cancer;Rengan;Int J Radiat Oncol Biol Phys,2004

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accelerated Hypofractionated Chemoradiation Followed by Stereotactic Ablative Radiotherapy Boost for Locally Advanced, Unresectable Non–Small Cell Lung Cancer;JAMA Oncology;2024-03-01

2. Personalized mid-course FDG-PET based adaptive treatment planning for non-small cell lung cancer using machine learning and optimization;Physics in Medicine & Biology;2022-09-13

3. Predicting personalised and progressive adaptive dose escalation to gross tumour volume using knowledge-based planning models for inoperable advanced-stage non-small cell lung cancer patients treated with volumetric modulated arc therapy;Biomedical Physics & Engineering Express;2022-03-04

4. Cone-Beam-CT Guided Adaptive Radiotherapy for Locally Advanced Non-small Cell Lung Cancer Enables Quality Assurance and Superior Sparing of Healthy Lung;Frontiers in Oncology;2020-12-09

5. Early Tumor and Nodal Response in Patients with Locally Advanced Non-Small Cell Lung Carcinoma Predict for Oncologic Outcomes in Patients Treated with Concurrent Proton Therapy and Chemotherapy;International Journal of Radiation Oncology*Biology*Physics;2020-02